Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
US-11077080-B2 · Aug 3, 2021 · US
This page is not indexed by search engines while we improve data quality.
Charveriat Mathieu patents
Charveriat Mathieu is listed as an inventor on 7 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Charveriat Mathieu |
| Total patents | 7 |
| First publication | Jan 8, 2015 |
| Latest publication | Aug 3, 2021 |
Notable patents
Publications ranked by popularity score, then publication date.
Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
US-10765670-B2 · Sep 8, 2020 · US
Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
US-2018177773-A1 · Jun 28, 2018 · US
Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
US-9750734-B2 · Sep 5, 2017 · US
Use of flecainide as an anti-connexin agent and method for potentiating the effects of a psychotropic drug
US-2016158213-A1 · Jun 9, 2016 · US
Use of anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
US-2015272915-A1 · Oct 1, 2015 · US
Use of anti-connexin agents for enhancing the therapeutic effect of acetylcholinesterase inhibitors
US-2015011584-A1 · Jan 8, 2015 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Commissariat Energie Atomique | 8 |
| Bio Modeling Systems Ou Bmsystems | 2 |
| Commissariat A Lenergie Atomique Aux Energies Alternatives | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K45/06 | 7 |
| A61P25/28 | 7 |
| A61K31/196 | 5 |
| A61K2300/00 | 5 |
| A61P43/00 | 4 |